January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Samyang Biopharm USA, Inc
Samyang Biopharm USA is transforming drug delivery for gene therapy and precision medicine based on its proprietary, non-viral, tissue- and cell-selective nucleic acid delivery platform called SENS™ (Stability Enhanced NanoShell).